Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysis

Fig. 2

Forest plot depicting improved overall survival outcomes with low and intermediate CRAFITY scores in the subgroup analysis according to BCLC stage. (A) The OS outcomes of BCLC A/B/C/D patients with CRAFITY score: 0. (B) The OS outcomes of BCLC A/B/C/D patients with CRAFITY score: 1. (C) The OS outcomes of BCLC B/C/D patients with CRAFITY score: 0

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us